Almirall Announces CFO Transition Plan and Appoints Jon U. Garay Alonso as CFO to Succeed Mike McClellan in August 2025
Almirall, S.A. (ALM) a global biopharmaceutical company based in Barcelona, today announced the appointment of Jon U. Garay Alonso as Chief Financial Officer and member of the company’s Management Board as of August 2025, succeeding Mike McClellan, who will leave the company in September 2025, after nearly six successful years as CFO.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250305566567/en/
Almirall HQ in Barcelona (Photo: Business Wire)
This planned transition is focused on maintaining business continuity and enabling the organization to keep and further build its strong trajectory towards achieving its ambition as European leader in medical dermatology.
Jon U. Garay Alonso is currently CFO at Camurus, a science-led, global pharmaceutical company focused on developing and commercializing innovative medicines with the potential to significantly improve treatment for patients with severe and chronic diseases within Central Nervous System (CNS) diseases, rare diseases, endocrine disorders, oncology and supportive care. Jon previously held positions with increasing seniority at Baxter, Gambro, Convatec, and Bristol Myers Squibb after having worked in different industry sectors before. Jon has bachelor’s and master’s degrees in business administration and has continued his professional education throughout his career. Jon will relocate from Lund, Sweden to Barcelona and report to Carlos Gallardo, Almirall Chairman and CEO.
"We are delighted to welcome Jon as CFO and member of Almirall’s management board. I am convinced that his expertise in the pharma sector and in finance and business will be important contributors to the further growth of our company, building on the work done by Mike and the Management Board in recent years. I want to thank Mike for his work as CFO of Almirall – he has played a pivotal role in the company’s development and recent growth. He leaves Almirall at a time of strength – as we have exceeded our 2024 guidance and are entering an era of sustained double-digit growth and margin expansion. As Mike is transitioning his role to Jon, we continue to be very confident in our strategy, commercial success, and our R&D capabilities which are the foundation for achieving our business ambition and leadership in medical dermatology.”
Carlos Gallardo, Almirall Chairman and CEO
About Almirall
Almirall is a global pharmaceutical company dedicated to medical dermatology. We closely collaborate with leading scientists, healthcare professionals, and patients to deliver our purpose: to transform the patients' world by helping them realize their hopes and dreams for a healthy life. We are at the forefront of science to deliver ground-breaking, differentiated medical dermatology innovations that address patients´ needs.
Almirall, founded in 1944 and headquartered in Barcelona, is publicly traded on the Spanish Stock Exchange (ticker: ALM, total revenue in 2024: €990 MM, over 2000 employees globally). Almirall products help to improve the lives of patients every day and are available in over 100 countries.
For more information, please visit https://www.almirall.com/
View source version on businesswire.com: https://www.businesswire.com/news/home/20250305566567/en/
Contacts
Corporate Communications
corporate.communication@almirall.com
Phone: (+34) 93 291 35 08
Investor Relations
investors@almirall.com
Phone: (+34) 93 291 30 87
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
State Street Onboards River Global to its Transfer Agency Service Supported by ZILO™6.3.2025 11:30:00 EET | Press release
State Street Corporation (NYSE: STT) today announced the successful onboarding of River Global as a client of its newly launched transfer agency service in the UK, supported by ZILO™, a FinTech specialising in global asset and wealth management software. State Street participated in ZILO’s Series A fundraising round in January 2024, a decision driven by State Street’s focus on addressing the need for modern digital solutions to improve cost effectiveness and operational efficiency within the investment management industry. Donna Milrod, global head of product, State Street, said: “We are pleased to welcome River Global as our first client of our re-entry to the UK transfer agency market. Transfer agency is the gateway to investors and distributors, and ZILO’s cloud-based and AI-enabled technology helps significantly reduce friction in the distribution process, providing a superior digital-first user experience, complementing our existing back-office offering.” Alex Hoctor-Duncan, Chief
Slate Asset Management Completes More Than €420 Million of Essential Real Estate Acquisitions in Germany Year to Date6.3.2025 09:00:00 EET | Press release
Slate Asset Management (“Slate” or the “Firm”), a global investor and manager focused on essential real estate and infrastructure assets, today announced that it has completed the acquisition of 45 grocery properties located in Germany, which are collectively valued at over €420 million. Slate acquired the properties in four individual portfolio transactions, which are expected to close in the first quarter of 2025 subject to standard closing conditions. The properties are well-located near major population centers throughout Germany and are fully leased under long-term agreements to some of Germany’s largest grocery and everyday goods distributors, including REWE Group, Schwarz Group, Edeka Group, and ALDI. “In a muted transaction environment, our European team has successfully executed nearly half a billion euros of essential real estate transactions in the first three months of the year,” said Sven Vollenbruch, Managing Director leading Slate’s European Investments. “We are very ple
EOLO Chooses Thales to Expand High-Speed Internet Access in Italy6.3.2025 09:00:00 EET | Press release
The European Union aims to ensure that all citizens have access to 1Gbps broadband by 2030 and EOLO selected Thales for its leading connectivity solutions. Achieving this vision requires innovative solutions like Fixed Wireless Access (FWA), which delivers high-speed internet to areas lacking traditional fiber or copper networks. FWA is crucial for connecting people in small towns and rural regions, supporting economic growth, and bridging the digital divide. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250305939446/en/ EOLO credit EOLO’s Vision for Faster Connectivity As Italy’s leading FWA provider, EOLO has been pioneering radio technology to deliver affordable, high-speed internet. Currently, the company serves more than 700,000 households and FWA connectivity can reach speeds of up to 300 Mbps in download. To furtherly improve customer experience and reach Italian territories with a service able to bridge digital spee
Galderma Delivers 2024 Record Net Sales of 4.410 Billion USD, up 9.3% Year-on-Year at Constant Currency 1 , and Record Core EBITDA of 1.031 Billion USD, While Preparing to Accelerate Its Growth Trajectory Into 2025 and Beyond6.3.2025 08:00:00 EET | Press release
Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its financial results for the full year 2024, delivering strong results for another consecutive year while making significant progress with its blockbuster platforms and future growth drivers. Record net sales: Achieved 4,410 million USD in net sales, up 9.3% year-on-year on a constant currency basis1, with volume-based growth fueled by focused execution and differentiated innovation Broad-based growth: Continued performance across all product categories with constant currency year-on-year growth of 9.6% for Injectable Aesthetics, 10.7% for Dermatological Skincare and 6.1% for Therapeutic Dermatology Focused execution: Continued execution of Galderma’s unique growth-focused Integrated Dermatology Strategy, supporting all product categories on a global scale and with omni-channel presence. Moreover, made significant headway with the company’s future growth drivers, including Nemluvio® (nemolizumab)
Ant International’s Risk Tech Solutions Win WDTA AI STR-02 Certification6.3.2025 04:00:00 EET | Press release
At the DWC AI STR Forum (Digital World Conference: AI Safety, Trust, and Responsibility Forum) by The World Digital Technology Academy (WDTA) in Hong Kong, AlipayHK became one of the first global tech operators to obtain a security certification on Large Language Model (LLM) applications in compliance with WDTA AI STR-02 Standards. This certification testifies to the strength of risk tech capabilities of Ant International, and marks a significant step in AI governance for Hong Kong. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250305979238/en/ Dr Tianyi Zhang, General Manager of Global Risk Management and Cybersecurity at Ant International speaking at the Global AI Action Summit in Hong Kong (Photo: Business Wire) WDTA, a non-governmental organization operating under the UN framework, issues The LLM Security Certification as part of its AI Safety, Trust, and Responsibility (AI STR) series of standards. This certification e
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom